SPDR S&P Biotech ETF (NYSEARCA:XBI) is LHM Inc.’s 9th Largest Position

LHM Inc. raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 22.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 45,775 shares of the exchange traded fund’s stock after buying an additional 8,361 shares during the period. SPDR S&P Biotech ETF comprises 1.5% of LHM Inc.’s investment portfolio, making the stock its 9th biggest position. LHM Inc. owned approximately 0.06% of SPDR S&P Biotech ETF worth $4,244,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XBI. Avoro Capital Advisors LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at $396,844,000. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of SPDR S&P Biotech ETF by 30.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares in the last quarter. Mirae Asset Securities USA Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth about $55,626,000. Jane Street Group LLC increased its stake in shares of SPDR S&P Biotech ETF by 68.7% during the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares in the last quarter. Finally, Baymount Management LP purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth about $34,160,000.

SPDR S&P Biotech ETF Trading Up 1.6 %

XBI opened at $102.43 on Friday. The firm has a market capitalization of $7.81 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The firm’s 50-day moving average price is $98.88 and its 200 day moving average price is $93.92.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.